Peptides and the FDA

There was an FDA Pharmacy Compounding Advisory Committee meeting in July 2026 discussing several peptides commonly used in functional and longevity medicine.

The peptides discussed included:

BPC 157

KPV

TB 500

MOTS c

DSIP or Emideltide

Semax

Epitalon

Are these FDA approved?

The July meeting did not mean these peptides were FDA approved. The committee was considering whether these substances should potentially be eligible for use as bulk substances in 503A. (Specific pharmacies)

compounded medications.

Why does this matter?

The meeting was important because these peptides are now undergoing more formal review of their...

Safety

Clinical evidence

Pharmacology

Potential therapeutic uses

Suitability for compounding

This brings more scientific and regulatory scrutiny to a field that has largely operated in a gray area.

What I want you to know:

As a functional medicine provider, I am watching this space closely.

These peptides are still an evolving area of medicine, and although I do offer peptides to SOME of my patients, they are often not be the starting point. Peptides are an added layer that we bring in when the terrain has been laid.

Some peptides that I have recently started using in my practice:

Oral BPC for gut health

Injectable KPV and BPC for joint aches and pains and soft tissue repair.

SEMAX and SELANK for anxiety, depression, mood stabilization.

GLPIs and GIPs for anti inflammatory effects, glucose control, and/or weight loss.

If you are interested and meeting with the Nurse Practitioner for a peptide consultation, please fill out the contact form on the home page of www.origofm.com .